Mei Lu1, Jia Li1, Loralee B Rupp2, Yueren Zhou1, Scott D Holmberg3, Anne C Moorman3, Philip R Spradling3, Eyasu H Teshale3, Joseph A Boscarino4, Yihe G Daida5, Mark A Schmidt6, Sheri Trudeau1, Stuart C Gordon7. 1. Department of Public Health Sciences, Henry Ford Health System, Detroit, MI, USA. 2. Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA. 3. Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. 4. Department of Epidemiology and Health Services Research, Geisinger Health System, Danville, PA, USA. 5. Center for Health Research, Kaiser Permanente-Hawai'i, Honolulu, HI, USA. 6. Center for Health Research, Kaiser Permanente-Northwest, Portland, OR, USA. 7. Division of Gastroenterology and Hepatology, Henry Ford Health System, Detroit, MI, USA.
Abstract
BACKGROUND & AIMS: Chronic hepatitis C virus (HCV)-related complications have increased over the past decade. METHODS: We used join-point regression modelling to investigate trends in these complications from 2006 to 2015, and the impact of demographics on these trends. Using data from the Chronic Hepatitis Cohort Study (CHeCS), we identified points at which the trend significantly changed, and estimated the annual percent change (APC) in rates of cirrhosis, decompensated cirrhosis and all-cause mortality, adjusted by race, sex and age. RESULTS: Among 11,167 adults with chronic HCV infection, prevalence of cirrhosis increased from 20.8% to 27.6% from 2006 to 2015, with adjusted annual percentage change (aAPC) of 1.2 (p <. 01). Although incidence of all-cause mortality increased from 1.8% in 2006 to 2.9% in 2015, a join-point was identified at 2010, with aAPCs of 9.6 before (2006 < 2010; p < .01) and -5.2 after (2010 ≤ 2015; p < .01), indicating a decrease in mortality from 2010 and onward. Likewise, overall prevalence of decompensated cirrhosis increased from 9.3% in 2006 to 10.4% in 2015, but this increase was confined to patients 60 or older (aAPC = 1.5; p = .023). Asian American and Black/African American patients demonstrated significantly higher rates of cirrhosis than White patients, while older patients and men demonstrated higher rates of cirrhosis and mortality. CONCLUSIONS: Although cirrhosis and mortality among HCV-infected patients in the US have increased over the past decade, all-cause mortality has decreased in recent years.
BACKGROUND & AIMS:Chronic hepatitis C virus (HCV)-related complications have increased over the past decade. METHODS: We used join-point regression modelling to investigate trends in these complications from 2006 to 2015, and the impact of demographics on these trends. Using data from the Chronic Hepatitis Cohort Study (CHeCS), we identified points at which the trend significantly changed, and estimated the annual percent change (APC) in rates of cirrhosis, decompensated cirrhosis and all-cause mortality, adjusted by race, sex and age. RESULTS: Among 11,167 adults with chronic HCV infection, prevalence of cirrhosis increased from 20.8% to 27.6% from 2006 to 2015, with adjusted annual percentage change (aAPC) of 1.2 (p <. 01). Although incidence of all-cause mortality increased from 1.8% in 2006 to 2.9% in 2015, a join-point was identified at 2010, with aAPCs of 9.6 before (2006 < 2010; p < .01) and -5.2 after (2010 ≤ 2015; p < .01), indicating a decrease in mortality from 2010 and onward. Likewise, overall prevalence of decompensated cirrhosis increased from 9.3% in 2006 to 10.4% in 2015, but this increase was confined to patients 60 or older (aAPC = 1.5; p = .023). Asian American and Black/African American patients demonstrated significantly higher rates of cirrhosis than Whitepatients, while older patients and men demonstrated higher rates of cirrhosis and mortality. CONCLUSIONS: Although cirrhosis and mortality among HCV-infectedpatients in the US have increased over the past decade, all-cause mortality has decreased in recent years.
Authors: C Bradley Hare; Jonathan A Morris; Alice Chu; Vincent Gotz; Jacqueline J Loveland; David Hodes; Winslow Klaskala Journal: Pharmacoepidemiol Drug Saf Date: 2006-02 Impact factor: 2.890
Authors: Stuart C Gordon; Paul J Pockros; Norah A Terrault; Robert S Hoop; Ami Buikema; David Nerenz; Fayez M Hamzeh Journal: Hepatology Date: 2012-10-09 Impact factor: 17.425
Authors: Philip R Spradling; Jian Xing; Loralee B Rupp; Anne C Moorman; Stuart C Gordon; Mei Lu; Eyasu H Teshale; Joseph A Boscarino; Mark A Schmidt; Yihe G Daida; Scott D Holmberg Journal: J Clin Gastroenterol Date: 2018-08 Impact factor: 3.062
Authors: Reena Mahajan; Jian Xing; Stephen J Liu; Kathleen N Ly; Anne C Moorman; Loralee Rupp; Fujie Xu; Scott D Holmberg Journal: Clin Infect Dis Date: 2014-02-12 Impact factor: 9.079
Authors: Scott D Holmberg; Mei Lu; Loralee B Rupp; Lois E Lamerato; Anne C Moorman; Vinutha Vijayadeva; Joseph A Boscarino; Emily M Henkle; Stuart C Gordon Journal: Clin Infect Dis Date: 2013-04-16 Impact factor: 9.079
Authors: Mei Lu; Jia Li; Loralee B Rupp; Scott D Holmberg; Anne C Moorman; Philip R Spradling; Eyasu H Teshale; Yueren Zhou; Joseph A Boscarino; Mark A Schmidt; Lois E Lamerato; Connie Trinacty; Sheri Trudeau; Stuart C Gordon Journal: J Viral Hepat Date: 2016-03-30 Impact factor: 3.728
Authors: Mei Lu; Jia Li; Talan Zhang; Loralee B Rupp; Sheri Trudeau; Scott D Holmberg; Anne C Moorman; Philip R Spradling; Eyasu H Teshale; Fujie Xu; Joseph A Boscarino; Mark A Schmidt; Vinutha Vijayadeva; Stuart C Gordon Journal: Clin Gastroenterol Hepatol Date: 2016-01-22 Impact factor: 11.382
Authors: J Li; S C Gordon; L B Rupp; T Zhang; J A Boscarino; V Vijayadeva; M A Schmidt; M Lu Journal: J Viral Hepat Date: 2014-01-29 Impact factor: 3.728
Authors: Anne C Moorman; Loralee B Rupp; Stuart C Gordon; Yuna Zhong; Jian Xing; Mei Lu; Joseph A Boscarino; Mark A Schmidt; Yihe G Daida; Eyasu H Teshale; Philip R Spradling; Scott D Holmberg Journal: Infect Dis Clin North Am Date: 2018-06 Impact factor: 5.982
Authors: Elizabeth A McGlynn; John L Adams; Jason Kramer; Amandeep K Sahota; Michael J Silverberg; Elizabeth Shenkman; David R Nelson Journal: JAMA Netw Open Date: 2019-06-05